Medtronic (MDT) Declares $0.50 Annual Dividend; 0.5% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Medtronic (MDT) Highlights New Data from CRYO4PERSISTENT AF Clinical Trial Evaluating Patients with Symptomatic Persistent AF Treated with Cryoballoon at 2018 ESC Congress
August 28, 2018 9:09 AM EDTMedtronic plc (NYSE: MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures. The study evaluated patients with symptomatic persistent... More
Medtronic, Inc. (MDT) PT Raised to $104 at Oppenheimer
August 22, 2018 9:10 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Medtronic, Inc. (NYSE: MDT) to $104.00 (from $96.00) while maintaining a Perform rating.
Lichtman commented, "Medtronic delivered its third consecutive quarter of strong top-line performance with F1Q19 underlying sales growth of 6.8%, ahead of guidance.... More
Medtronic, Inc. (MDT) PT Raised to $101 at Wells Fargo
August 22, 2018 7:44 AM EDTWells Fargo analyst Larry Biegelsen raised the price target on Medtronic, Inc. (NYSE: MDT) to $101.00 (from $95.00) while maintaining a Market Perform rating.
... MoreMedtronic, Inc. (MDT) PT Raised to $105 at Morgan Stanley
August 22, 2018 7:01 AM EDTMorgan Stanley analyst David Lewis raised the price target on Medtronic, Inc. (NYSE: MDT) to $105.00 (from $95.00) while maintaining a Equalweight rating.
... More